A Bertolini, R Fiorotto, M Strazzabosco - Seminars in immunopathology, 2022 - Springer
Bile acids participate in the intestinal emulsion, digestion, and absorption of lipids and fat- soluble vitamins. When present in high concentrations, as in cholestatic liver diseases, bile …
A Zhuge, S Li, Y Yuan, S Han, J Xia, Q Wang, S Wang… - Redox Biology, 2023 - Elsevier
Obeticholic acid (OCA) has been examined to treat non-alcoholic steatohepatitis (NASH), but has unsatisfactory antifibrotic effect and deficient responsive rate in recent phase III …
Recent studies on liver disease burden worldwide estimated that cirrhosis is the 11th most common cause of death globally, and there is a great need for new therapies to limit the …
Abstract Background & Aims Obeticholic acid (OCA) has recently been restricted in patients with primary biliary cholangitis (PBC) with “advanced cirrhosis” because of its narrow …
T Zhang, S Feng, J Li, Z Wu, Q Deng, W Yang, J Li… - Archives of …, 2022 - Springer
Farnesoid X receptor (FXR) plays an indispensable role in liver homeostasis and has been a promising drug target for hepatic diseases. However, the concerns of undesired biological …
LR de Haan, RF van Golen, M Heger - Pharmacological reviews, 2024 - ASPET
The liver has the unique capacity to regenerate, and up to 70% of the liver can be removed without detrimental consequences to the organism. Liver regeneration is a complex process …
R Wang, T Yuan, J Sun, M Yang, Y Chen… - Frontiers in …, 2022 - frontiersin.org
Cholestasis, characterized by disturbance of bile formation, is a common pathological condition that can induce several serious liver diseases. As a kind of trigger, estrogen …
C Song, X Long, J He, Y Huang - Frontiers in Pharmacology, 2023 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is common chronic metabolic liver disorder which is associated with fat accumulation in the liver. It causes a wide range of pathological effects …